Global Precision Medicine & Biomarkers Leaders Summit

When

21st-22nd Sep 2017
Agenda in development. See last year's below:

Where

Munich, Germany
Venue to be confirmed

See Last Year's Agenda

The 4th Global Precision Medicine & Biomarkers Leaders Summit

EXAMINING GROUNDBREAKING BIOMARKER, COMPANION DIAGNOSTIC, IMMUNO-ONCOLOGY, GENOMIC & BIG DATA RESEARCH TO FACILITATE THE DEVELOPMENT OF IMPACTFUL PERSONALIZED TREATMENTS FOR PATIENTS

The 2017 meeting is currently in production – Last year’s final agenda is available for download

What will be covered:

  • Strategies and Technologies to Deliver Precision Medicine
  • Immuno-Oncology Biomarkers
  • Integrating Personal Genomics, Big Data and Bioinformatics
  • Companion Diagnostic Partnerships & Development
  • Biomarkers in Clinical and Translational Development

225+ senior level attendees
60+ expert speakers
Sell out Exhibition room
1-2-1 partnership meetings
50+ panel/ roundtable or individual presentations

A selection of our 2016 speakers included

Key Themes

THE AGENDA IS CURRENTLY UNDER DEVELOPMENT, AND WILL BE RELEASED IN THE NEXT FEW WEEKS.

This expanding international event attracts the leading authorities worldwide working in companion diagnostics, big data, genomics, biomarkers, immuno-oncology and other facets of precision medicine.

It has been praised for its stimulating, interactive and engaging environment where it brings together a multi-disciplined community whose aim is to develop ground breaking and impactful treatments for patients.

The key areas of study for the 2017 meeting include

Day 1 Track 1
Strategies and Technologies to Deliver Precision Medicine

  • Current & future perspectives – Innovative initiatives, strategies and approaches
    • Integrated genomic / multi omic approaches
  • Delivering superior outcomes for patients through personalized healthcare
  • Technologies to enable Precision Medicine
    • Gene editing to deliver Precision Medicine
  • Innovative clinical trial design
  • Understanding physician, payer and patient perspectives
  • Economics for precision medicine – Adding value
    • Investment, Incentivising pricing & reimbursement strategies
    • Market access considerations
  • Ethical, regulatory & IP implications of individualizing medicine

Panel Discussion – Identifying the most promising directions for Precision research

Day 1 Track 2
Immuno-oncology Biomarkers

  • Strategies
  • Predictive biomarkers
  • Immune checkpoint inhibitors
  • Immune response monitoring
  • Clinical trials
  • Circulating biomarkers
    • Circulating Tumour DNA (ctDNA) – detection & monitoring – unlocking realtime information
    • Liquid biopsies – clinical utility

Panel Discussion – Precision Immuno-oncology where are we heading?

Day 1 Track 3
Integrating Personal Genomics, Big Data and Bioinformatics

  • Data driven precision medicine
  • Technologies for successful collection & storage of data
  • Overcoming challenges in data sharing and analysis
  • Big data / Healthcare analytics
  • Integrating (multi-source) data into decision making processes
  • Effective data interpretation for decision support
  • Linking technologies to the bedside

Panel Discussion – Fulfilling the potential of big data

Day 2 Track 1
Companion Diagnostic Partnerships & Development

  • CDx strategies and accelerating development
    • Evolution of companion diagnostics
    • Delivering a successful biomarker strategy alongside a companion diagnostic
  • Lessons learnt and case studies from successful CDx collaborations & approvals
    • CDx development in Immuno-oncology
    • PDL1 Assays
  • Rx-Dx partnerships, integration and co-development
  • Overcoming regulatory issues; updates and future developments
  • Reimbursement, market access & commercialization
  • Complementary diagnostics

Panel Discussion – Diagnostics – Regulation and reimbursement challenges

Day 2 Track 2
Biomarkers in Clinical and Translational Development

  • Patient selection biomarkers and strategies
    • Stratification
    • Genomic profiling strategies
  • Clinical and translational biomarkers
    • Clinical biomarker discovery
    • Biomarker validation & qualification
    • Digital biomarkers

 

Read Last Year's Agenda

Newsletter

Global Precision Medicine and Biomarkers Leaders Summit

Get news about new precision medicine and biomarker developments research and applications direct to your inbox.

Subscribe

Previous Attendees

Abbott Molecular
4SC AG
AbbVie
ACTA
Advanced Technology Company
Advances in Precision Medicine
ADVentura Capital SL
Affymetrix
Aleris-Hamlet Hospitals
Almac
Alta Innovations Ltd
Analytics Engines
ANGLE
Arno Therapeutics
Astellas Pharma Inc.
AstraZeneca
Asuragen
Baillie Gifford
Barts Health NHS Trust
Baxalta
Baxter
Baylor College of Medicine/Texas Children’s Hospital
Belgian Brain Council
Berg
BIOBASE
Biocrates Life Sciences AG
Biogazelle
Biologische Heilmittel Heel GmbH
BioM Biotech Cluster Development GmbH
bioMcon – bio-math-consulting GmbH
Bioneer A/S
Bluebee
Blue-Key
BMC Medicine (BioMed Central)
BMS
Boehringer Ingelheim
Bracco Imaging SpA
BUPA
Cancer Research UK
CASMI
Central University of Ecuador, Quito, Ecuador
Cergentis
Cerner Corporation
CETICS Healthcare Technologies GmbH
Clovis Oncology
Comprehensive Biomarker Center GmbH
Cooley (UK) LLP
Covance Inc.
CRUK
Debiopharm International SA
Definiens AG
Department of Veterans Affairs
DNA Genotek
DNAlytics S.A.
DNAnexus UK
e:Med Systems Medicine
Eagle Genomics
EAPM
Eisai
Elsevier Ltd
EPEMED
Estonian Genome Center, University of Tartu
F. Hoffmann-La Roche Ltd.
Faculty of Science and Technology, University of Westminster
FDA
Ferrer inCode
Forest Research Institute
Frost & Sullivan
Future Science Group/GenomicsNet
Galapagos NV
GE Healthcare
GeneFirst
Genmab B.V.
Genomics England
GlaxoSmithKline
GNS Healthcare
Goldsmiths, University of London
Great Ormond Street Hospital for Children
Grünenthal GmbH
GSK
Guy’s and St Thomas NHS Trust
H3 Biomedicine
Harvard Medical School/Boston Children’s Hospital
Healthcare Strategies Group
Histologix Ltd
Human Longevity Inc.
I3h – Institute for Interdisciplinary Innovation in Healthcare
Ignyta
Illumina Inc
Imperial College London
InnVentis
Institut Curie
Institute for Systems Biology
Institute of Cancer Research
Integrated DNA Technologies
International Journal of Functional Informatics and Personalised Medicine (IJFIPM)
Intomics
Ipsen
IRCCS Istituto Tumori Bari Italy
Irycis
Jackson Laboratory
Janssen Diagnostics
Janssen Pharmaceutica
Johnson & Johnson
Journal of Personalized Medicine
Keele University
King Abdullah University of Science and Technology
King’s College Hospital NHS Foundation Trust
King’s College London
KU Leuven
Leiden University Medical Center
LEO Pharma
London Biotech Ltd
London North West Healthcare NHS Trust
Ludger Ltd.
Martina Kaufmann Strategic Consulting
Max Planck institute for Molecular Genetics
Mayo Clinic
MedGenome Inc.
Medical University of Graz, Institute of Pathology
MedImmune
AstraZeneca
Menarini Silicon Biosystems
Merck
Meso Scale Diagnostics, L.L.C.
Metabogen
Metabolon
Molecular Ninja Therapeutics
Momenta Pharmaceuticals
MRC-NIHR National Phenome Centre, Imperial College London
MSD
MSD UK
Mundipharma Research GmbH & Co.KG
Myriad Genetics Ltd
Myriad RBM, Inc.
NanoString Technologies
NCTR
Nebion AG
NNF Center for Protein Research
Norwegian University of Science and Technology
Novartis Vaccines & Diagnostics
Novo Nordisk Foundation Center for Protein Research
Novogene Co.,LTD
NRgene
Nuffield Health
Office of Health Economics
Olink Bioscience
Olivia Newton-John Cancer Research Institute
Oracle
OracleBio
Oxford University
Oxford University Hospitals NHS Foundation Trust
Paris Descartes University
Pfizer
Pharmacogenetics & Strat Med Network
Pierre Fabre
Pistoia Alliance
Polish Academy of Sciences
PPD
Precision Medicine Catapult
Prize4Life
Q2 Solutions
QIAGEN
Queen Mary University of London
Quintiles Central Laboratory
Radboud University Medical Center
Randox Laboratories Ltd
Regeneron Pharmaceuticals
Roche
Roche Diagnostics
Royal College of Surgeons in Ireland
Royal Marsden Hospital
Sage Bionetworks
Sanofi
SCIEX
Select Sciences
Serametrix
SFL Regulatory Affairs & Scientific Communication, Switzerland
Sichuan Primed Bio-Tech Co., Ltd.
Silicon Biosystems spa
SomaLogic, Inc.
Sophia Genetics
SOTIO
Stevenage Bioscience Catalyst
SV Life Sciences
Synexa Life Sciences
Sysmex Inostics
SystemsX.ch
Takeda Development Center of America
Technical University of Denmark
Technology Strategy Board
Tepnel Pharma Services
Teva Pharmaceuticals
The Institute of Cancer Research
The Technology Partnership plc (TTP)
Thermo Fischer Scientific
Thomson Reuters
Tissue Solutions Ltd
TNO
Top Medical Tech ( Europe) Co., Ltd
Toshiba Medical Visualisation
Transgene
Trovagene
Trovagene Inc
UCL
UK Pharmacogenetics & Stratified Medicine Network
Unilabs
Unilever
University College London
University Hospital Birmingham
University Marburg
University of Athens
University of Basel and Wyss Center Zuerich
University of Bradford
University of California, Irvine
University of Cambridge
University of Cambridge. Department of Physiology, Development and Neuroscience
University of Colorado
University of Copenhagen
University of Dundee
University of Huddersfield
University of Kent
University of Leeds
University of Leicester
University of Liverpool
University of Malta
University of Manchester
University of Minnesota
University of Namur & NDA
University of Newcastle
University of North Carolina at Chapel Hill
University of Oxford/UK Biobank
University of Reading
University of Sheffield
University of Southampton
University of the Witwatersrand
University of Wales
University of Western Sydney
University of Westminster
University of Westminster, Dept of Biomedical Sciences
US Food and Drug Administration
Vertex Pharmaceuticals Europe Ltd
Xenon Pharmaceuticals
Yonsei University
Yotta Biomed
ZIOPHARM Oncology

Newsletter

Get the new agenda

Be the first to get the agenda when it is ready for publication.

Our Sponsors

Confirmed sponsors for the 4th Global Precision Medicine & Biomarkers Leaders Summit

View All Our Sponsors

Venue

The Global Precision Medicine & Biomarkers Leaders Summit is moving to Munich, Germany for the first time!

We are currently in discussion with several venues and as soon as we have found the best rate for attendees, the venue details will be released.

Accommodation will be available at a preferential rate. A secure link will be sent to all attendees a little nearer the time.

Register

Step 1: Click to Choose Package

Standard Fee

1,499.00€

Click to select

Academic Fee

599.00€

Click to select

Solution Provider Fee

1,899.00€

This fee applies to organisations offering services and/or business & technology solutions and also to business consultants.

We accept the following cards through Worldpay
  • Visa
  • Visa Electron
  • Mastercard
  • Maestro
  • JCB

Step 2: Delegate Information

Conference Sponsors

  • Intomics
    Platinum Sponsor
  • OncoDNA
    Gold Sponsor
  • Novogene
    Exhibitor & Content Sponsor

Sponsorship

Sponsors and exhibitors at our conferences have the opportunity to meet and form partnerships with delegates on a formal and informal basis in a relaxed and professional atmosphere.

Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximize return on investment.

If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.

Twenty-Minute Prearranged One-to-One Meetings

Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time. 

Pre or Post Event Workshops

Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.

Pre-Event Marketing & Branding

Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags. 

Exhibition

Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.

Speaking Opportunities

Options include:

  • 30-minute speaker presentations
  • Chairing / panelist positions during a 30-minute panel discussion
  • Hosting a 1-hour workshop within the conference program
Sponsorship Opportunities

For further details please contact
Steve Hambrook, Conference Director
Telephone +44 (0) 1865 849841 or
email sponsorship@globalengage.co.uk

Contact us about sponsoring the
Global Precision Medicine & Biomarkers Leaders Summit.

Call us on +44 (0)1865 849 841

For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.

Media Partners

If you are interested in partnering with us, please contact jane@globalengage.co.uk.

  • Absave
  • Biocompare
  • Biomedicines
  • Biosave
  • Cancers
  • Global Information
  • Healthcare
  • Hospitals Management
  • Informatics
  • International Journal of Functional Informatics and Personalised Medicine
  • Journal of Biotechnology
  • Labsave
  • Pharmaceutical Tech
  • PharmaVOICE
  • Pharmaceutical Daily
  • RareBase
  • SciDoc Publishers
  • Select Science
  • Swiss Biotech Association
  • Technology Networks